Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Director departure
Letter to company
Asset disposition
Appointed director
|
|
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/30/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/08/2022 |
4/A
| Rosol Michael Stanley (Chief Medical Officer) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 100,000 options
@ $1.08, valued at
$108k
|
|
| 06/01/2015 |
4/A
| FORD BRENDAN A (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 11/08/2013 |
4/A
| FORD BRENDAN A (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 03/27/2013 |
4/A
| PYKETT MARK JEROME (Pres. & CEO) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 03/27/2013 |
4/A
| PYKETT MARK JEROME (Pres. & CEO) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 01/20/2012 |
4/A
| LARSON BRENT L (SVP, CFO, Treas & Secy) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 01/20/2012 |
4/A
| BROWN RODGER A (Vice President) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC. |
|
|